---
canonical_url: https://www.stockexpertai.com/earnings/acn
last_updated: 2026-05-03T21:42:56.111Z
---

# Accenture plc (ACN) Q4 FY2026 Earnings Preview

> This content was automatically generated with FMP live data + Q2 FY2026 earnings call transcript. Generated: 2026-05-03T21:42:54.828Z. Educational tool, not investment advice.

---

## Quick Summary

| Field | Value | Source |
|---|---|---|
| Price | $179.83 (▲ 0.63%) | fmp:quote |
| Market Cap | $110.7B | fmp:profile |
| 52w range | $173.65 – $325.71 | fmp:quote |
| Earnings | Thu 18 Jun | fmp:earnings-history |
| EPS estimate | $3.68 (+5% YoY) | fmp:earnings-estimate |
| Revenue estimate | $18.8B | fmp:earnings-estimate |
| Beat streak | 7/4 | fmp:earnings-history |
| Rating | A- (overall 4/5) | fmp:ratings |
| Analyst median target | $300 (+66.8% upside) | fmp:price-target-consensus |
| MoonshotScore | 40/100 | derived |
| Council | 4/6 bullish | derived |
| Munger verdict | Undervalued | derived |

## Accenture plc — Q4 FY2026 Expectations

Q4 consensus: revenue <strong data-source="fmp:earnings-estimate" data-field="estimates.next.revenueAvgLabel">$18.8B</strong><sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.revenueAvg" title="FMP est">[FMP est]</sup>, EPS <strong data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">$3.68</strong><sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg" title="FMP est">[FMP est]</sup>. 7 consecutive quarters of beat<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.beatStreakCount" title="FMP earnings">[FMP earnings]</sup>.

## Quick Take

**Score:** A- · **Stance:** BUY · **Council:** 4/6 · **Moonshot:** 40

= MoonshotScore <strong>40</strong><sup class="cite" data-source="derived" data-field="moonshot.score" title="9-pillar formula">[9-pillar formula]</sup> + Council <strong>4/6</strong><sup class="cite" data-source="derived" data-field="council.bullishCount" title="6-lens rule">[6-lens rule]</sup>. Form 4: 0 transactions<sup class="cite" data-source="fmp:insider-trading" data-field="insider.txCount" title="FMP Form 4">[FMP Form 4]</sup>.

## Watchlist (6 metrics)

### 1. Revenue Growth

Accenture delivered $18 billion of revenue, growing 4% in local currency and taking significant market share.

> "We delivered another strong quarter with $18 billion of revenue, growing 4% in local currency and once again taking significant market share."
> — Julie T. Sweet, CEO, Investor Focus · Q2 FY2026

### 2. Operating Margin Expansion

Accenture delivered 30 basis points of operating margin expansion with strong EPS growth year-over-year.

> "We delivered 30 basis points of operating margin expansion with strong EPS growth year-over-year, generating significant free cash flow while investing significantly in our business."
> — Julie T. Sweet, CEO, Risk Indicator · Q2 FY2026

### 3. Ai Talent Pool

Accenture now has over 85,000 AI and data professionals already exceeding our goal of 80,000 professionals by the end of fiscal 2026.

> "We now have over 85,000 AI and data professionals already exceeding our goal of 80,000 professionals by the end of fiscal 2026."
> — Julie T. Sweet, CEO, Investor Focus · Q2 FY2026

### 4. Large Client Bookings

Accenture had a record 41 clients with quarterly bookings greater than $100 million, demonstrating the continued demand for reinvention at scale.

> "We had a record 41 clients with quarterly bookings greater than $100 million, bringing us to 74 of these bookings in the first half, 12 more than this time last year, demonstrating the continued demand for reinvention at scale."
> — Julie T. Sweet, CEO, Investor Focus · Q2 FY2026

### 5. Acquisition Strategy

Accenture now expects to deploy $5 billion in acquisitions this year with capacity to do more for the right opportunities.

> "We closed 3 strategic acquisitions, deploying $1.6 billion of capital, and we now expect to deploy $5 billion in acquisitions this year with capacity to do more for the right opportunities."
> — Julie T. Sweet, CEO, Investor Focus · Q2 FY2026

### 6. Fixed Price Work

Within bookings, the percentage of our work, which is fixed price, continues to increase over 60% in FY '25.

> "Within bookings, the percentage of our work, which is fixed price, continues to increase over 60% in FY '25."
> — Angie Park, CFO, Investor Focus · Q2 FY2026


## MoonshotScore Pillars

| Pillar | Score | Level | Evidence |
|---|---|---|---|
| Revenue Growth | 1.0 | weak | Q2 vs Q3: growth slowing (+1.8%, below threshold) |
| Gross Margin | 3.0 | weak | Q2: average margin (30.3%) |
| Operating Leverage | 1.0 | weak | op margin average (13.8%) |
| Cash Runway | 10.0 | strong | FCF very strong ($3.7B, 24.5× CapEx) |
| R&D Intensity | 3.0 | weak | low R&D investment (1.1%, weak innovation) |
| Price Momentum | 4.0 | medium | RSI 38.1 weak momentum, 50d below |
| News Sentiment | 6.0 | medium | majority buy (64%) |

**Formula:** sum(pillar.score) / (count * 10) * 100. Each pillar deterministic from FMP. Source maps in pillar.formula.

## Council (7-Lens)

| Name | Stance | Context |
|---|---|---|
| Ray Dalio | bull | macro · target upside +66.8% |
| Ken Griffin | bear | flow · 50d MA below |
| Jim Simons | neutral | quant · RSI 38 |
| Klarman | bull | value · target upside +66.8% |
| Buffett | bull | quality · ROE score 5/5 |
| Munger | bull | valuation · target upside +66.8% |

**Formula:** Each lens uses deterministic rule on bundle data. Logged in member.contextTr.

## Munger Lens

- **Verdict:** Undervalued
- **Financial Health:** Strong
- **Margin of Safety:** Strong
- **Interest Coverage:** Adequate
- **ROIC vs WACC:** Healthy

**Formula:** verdict=upside>25?Undervalued:>0?Fairly Valued:Overvalued. Each lens deterministic from FMP ratings + priceTarget.

## Technical Levels

- **RSI(14):** 38.1 — momentum zayıf — oversold yakınında değil ama alıcı baskısı az
- **50d MA:** $196 — hisse %8.2 altında — kısa vadeli direnç
- **200d MA:** $240 — hisse %25.2 altında — uzun vadeli baskı
- **Volume (10d):** -24%

## Past Performance (4 Quarters)

| Quarter | EPS Actual | EPS Estimate | Result | Reaction |
|---|---|---|---|---|
| Q3 FY25 | $3.49 | $3.35 | BEAT | +3.4% |
| Q4 FY25 | $3.03 | $2.98 | BEAT | +2.8% |
| Q1 FY26 | $3.94 | $3.74 | BEAT | +0.8% |
| Q2 FY26 | $2.93 | $2.84 | +3.2% EPS | -1.7% |

Q2 (March 19, 2026): EPS $2.93 vs $2.84 est<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.history.0" title="FMP">[FMP]</sup>, +3.2% beat. D+1 movement: -1.7%<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.timeline.3.reactionLabel" title="FMP D+1">[FMP D+1]</sup>. Decline despite beat — market reacted to guidance, not numbers.

## 3 Scenarios

### Scenario A · Beat
**Q4 EPS > $3.68 + CapEx discipline**

Threshold: EPS > $3.68<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est]</sup>.

Target: Break above median target $300<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.median">[FMP target]</sup>; high target $330<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.high">[FMP]</sup> upper bound.

### Scenario B · In-Line
**EPS ≈ $3.68 + CapEx < $149.7M**

Threshold: EPS ≈ $3.68<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est]</sup>, Q4 CapEx < $149.7M<sup class="cite" data-source="fmp:cashflow" data-field="cashflow.qPrev.capexLabel">[FMP]</sup>.

Target: Consolidation in the band between current $180<sup class="cite" data-source="fmp:quote" data-field="quote.price">[FMP]</sup> and median $300<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.median">[FMP]</sup>.

### Scenario C · Miss
**EPS < $3.57 or CapEx ≥ $149.7M**

Threshold: EPS < $3.57<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est×0.97]</sup>.

Target: Current $180 below SMA200 $240<sup class="cite" data-source="fmp:technical" data-field="technical.sma200">[FMP]</sup>, if rejection continues, $204<sup class="cite" data-source="derived" data-field="technical.sma200" data-formula="round(sma200*0.85)">[derived]</sup> support activates.

## Risk Notes

### Primary segment below threshold
Q2: EPS $2.93 vs $2.84 beat<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.history.0" title="FMP">[FMP]</sup>, stock -1.7% D+1<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.timeline.3.reactionLabel" title="FMP">[FMP]</sup>.

### Backlog concentration
No RPO/backlog concentration disclosed in Q2 earnings call.

### Insider trading
Form 4 data is marked in the table — this page does not generate assumptions for this stock.

| Executive | Action | Amount | Date |
|---|---|---|---|


**Net:** — (0 transactions · 0 sells · 0 buys) · Q2 FY26

### CapEx shock
Q2 CapEx $149.7M<sup class="cite" data-source="fmp:cashflow" data-field="cashflow.qPrev.capexLabel" title="FMP cashflow">[FMP cashflow]</sup>. Q2 op margin 13.8%<sup class="cite" data-source="fmp:income" data-field="income.quarters.0.operatingMargin" title="FMP op margin">[FMP op margin]</sup> — this level in Q4 is sensitive to CapEx revision risk.

## Wall Street Consensus

- **Median target:** $300 (+66.8% upside vs current $180)
- **High / Low:** $330 / $265
- **Buy / Hold / Sell:** 18 / 10 / 0
- **Analyst count:** 1 (last quarter), 101 all-time

## Additional Transcript Insights

### 1. revenue_growth

**Claim:** Accenture delivered $18 billion of revenue, growing 4% in local currency and taking significant market share.

**Evidence (transcript):** "We delivered another strong quarter with $18 billion of revenue, growing 4% in local currency and once again taking significant market share."

**Numbers:** $18 billion, 4%

### 2. record_bookings

**Claim:** Accenture had record bookings of $22.1 billion, bringing H1 bookings to a total of $43 billion.

**Evidence (transcript):** "We had record bookings of $22.1 billion, bringing H1 bookings to a total of $43 billion."

**Numbers:** $22.1 billion, $43 billion

### 3. large_client_bookings

**Claim:** Accenture had a record 41 clients with quarterly bookings greater than $100 million, demonstrating the continued demand for reinvention at scale.

**Evidence (transcript):** "We had a record 41 clients with quarterly bookings greater than $100 million, bringing us to 74 of these bookings in the first half, 12 more than this time last year, demonstrating the continued demand for reinvention at scale."

**Numbers:** 41, $100 million, 74, 12

### 4. operating_margin_expansion

**Claim:** Accenture delivered 30 basis points of operating margin expansion with strong EPS growth year-over-year.

**Evidence (transcript):** "We delivered 30 basis points of operating margin expansion with strong EPS growth year-over-year, generating significant free cash flow while investing significantly in our business."

**Numbers:** 30

### 5. acquisition_strategy

**Claim:** Accenture now expects to deploy $5 billion in acquisitions this year with capacity to do more for the right opportunities.

**Evidence (transcript):** "We closed 3 strategic acquisitions, deploying $1.6 billion of capital, and we now expect to deploy $5 billion in acquisitions this year with capacity to do more for the right opportunities."

**Numbers:** 3, $1.6 billion, $5 billion

### 6. ai_talent_pool

**Claim:** Accenture now has over 85,000 AI and data professionals already exceeding our goal of 80,000 professionals by the end of fiscal 2026.

**Evidence (transcript):** "We now have over 85,000 AI and data professionals already exceeding our goal of 80,000 professionals by the end of fiscal 2026."

**Numbers:** 85,000, 80,000, 2026

### 7. fixed_price_work

**Claim:** Within bookings, the percentage of our work, which is fixed price, continues to increase over 60% in FY '25.

**Evidence (transcript):** "Within bookings, the percentage of our work, which is fixed price, continues to increase over 60% in FY '25."

**Numbers:** 60%, 25


---

*Data source: FMP (live query, 2026-05-03), Q2 FY2026 earnings call transcript (Translated to EN with Gemini 2.0 Flash). Educational tool, not investment advice.*
